Although epidemiologic studies have shown an association between vascular disease and hyperhomocysteinemia, large randomized controlled trials have shown that lowering homocysteine levels in these patients does not reduce the number of myocardial infarctions or strokes, or improve mortality rates
Excellent service, fast shipping and great product
ScheduleDaily subcutaneous injections for 8 to 12 weeks (extend to 16 weeks if desired)
(10 g or 10 ng/kg/day), topical (1.0 g in cream), or per-oral (0.16 g/mL in drinking water) over 90 days and described directional improvements across biomechanical, functional, macroscopic, and histological endpoints, though specific effect sizes and p-values are not reported in the abstract
Frequently Asked Questions About AOD-9604 5mg Research Peptide Q: What is AOD-9604 5mg used for in research